Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets.
about
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.Imaging of multiple sclerosis: role in neurotherapeutics.Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach.Inferences and Power Analysis Concerning Two Negative Binomial Distributions with An Application to MRI Lesion Counts Data.Blinded sample size reestimation with count data: methods and applications in multiple sclerosis.Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials.A longitudinal model for magnetic resonance imaging lesion count data in multiple sclerosis patients.A parametric model fitting time to first event for overdispersed data: application to time to relapse in multiple sclerosis.Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 studyEffects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.Advances in imaging to support the development of novel therapies for multiple sclerosis.Reliable measurements of brain atrophy in individual patients with multiple sclerosis.Modeling lesion counts in multiple sclerosis when patients have been selected for baseline activity.Modeling MR imaging enhancing-lesion volumes in multiple sclerosis: application in clinical trials.Power analyses for negative binomial models with application to multiple sclerosis clinical trials.MRI-based clinical trials in relapsing-remitting MS: new sample size calculations based on a longitudinal model.A Bayesian adaptive dose selection procedure with an overdispersed count endpoint.Safety and efficacy of helminth treatment in relapsing-remitting multiple sclerosis: Results of the HINT 2 clinical trial.Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis.Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpoint
P2860
Q30816299-7BF9733C-63A1-49D0-A415-397515A573C6Q30989935-AB31679B-7D4F-4A98-AB87-695F376FF0CAQ31138740-615DF00B-A096-4262-ABD9-EFE993F46F41Q33403764-4064645A-718E-4E22-A45B-B6B2B0739B89Q33530479-16A4B11C-42BF-4F16-8AB9-154992D4CD37Q33634866-A863D0B6-9106-40D7-A42E-F7F0ECCDEFBDQ34037214-C0FA440A-3B85-4BF3-89B9-649C843B9274Q34074336-EE394210-C49A-41D8-BD2C-058AC32618AFQ34168414-C35F3D27-ABE6-4327-9665-0180D2112E1AQ36052912-207BBF63-53A6-498F-8EA3-3F57F5AE2FECQ37227079-31ED753C-8157-4716-AD00-12E79EA80BC4Q37991519-CA2D11DC-01C3-4E00-9DD5-C11FD657E9C3Q39335452-2979347E-E479-4C5F-B06D-E80B2D054E2DQ42165447-6E8FAC65-ED94-4363-8938-0A6C25E983DCQ43562375-D8BE80B7-8B4F-4040-924D-45ADE84A3C05Q44734674-D6107439-BBB8-4567-9754-B672FFA6701FQ45988953-AE2EEB64-509A-4A97-9C54-7C1B0080CE51Q46142198-02CA1EE9-66EE-4D4E-A86F-884FE846BBA9Q48003577-24255018-5894-4CCA-A335-F51CD1AE2F6EQ49072224-83EB44F1-0350-4347-86A1-2F9DE594C5BAQ49108072-E0E0F9EB-3311-41FF-9CA6-A06CB1C687D9Q58073805-BA74FC9A-2E9E-4FEF-B465-B19C7A37AD08
P2860
Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical trials of multiple sc ...... ions based on large data sets.
@ast
Clinical trials of multiple sc ...... ions based on large data sets.
@en
type
label
Clinical trials of multiple sc ...... ions based on large data sets.
@ast
Clinical trials of multiple sc ...... ions based on large data sets.
@en
prefLabel
Clinical trials of multiple sc ...... ions based on large data sets.
@ast
Clinical trials of multiple sc ...... ions based on large data sets.
@en
P2093
P2860
P356
P1476
Clinical trials of multiple sc ...... ions based on large data sets.
@en
P2093
P2860
P304
P356
10.1136/JNNP.70.4.494
P407
P577
2001-04-01T00:00:00Z